BioSpace News Archive

Guardion Health Sciences, Inc., announced the closing of its previously announced underwritten public offering of 24,500,000 shares of its common stock and Series B warrants to purchase up to 24,500,000 shares of the Company’s common stock.

Moberg Pharma AB (publ)'s (“Moberg Pharma” or the “Company”) Annual General Meeting took place today in the Company’s premises in Bromma

System Offers at Home Therapy Management for DBS patients

Membership demonstrates commitment to transforming health and well-being in indoor environments

Joseph Miller, MD, MS, a physician at the Henry Ford Health System in Detroit, MI, and a key Principal Investigator on CalciMedica’s initial acute pancreatitis clinical study of its calcium release-activated calcium channel inhibitor CM4620-IE, presented on the study at the annual meeting of the American College of Emergency Physicians being held in Denver, CO from October 27-30.

Conformis, Inc., a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient-specific joint replacement implants designed to fit each patient’s unique anatomy, announced financial results for the third quarter ended September 30, 2019.

Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company developing novel precision antibacterials to treat serious drug-resistant infections, announced the appointment of David Altarac, M.D., MPA as Chief Medical Officer, effective November 4, 2019.

Kaleido Biosciences, Inc., a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and improve human health, announced financial results for the third quarter ended September 30, 2019, and provided a corporate update.

Enrollment on-track in pivotal Phase 3 clinical trials to support registration of sparsentan for patients with FSGS and IgAN

Immunomedics, Inc., a leading biopharmaceutical company in the area of antibody-drug conjugates, reported financial results for the third quarter of 2019.